On May 11, 2024, China State Administration for Market Regulation (SAMR) released Clinical Trial Quality Management Standard for Foods for mag citrate tabletsSpzinc 50 mg gluconateecial Medmagnesium direct citrate 375 mgical Purposalgaecal calcium and strontium citrate supplemente (hereinafter “FSMP Clinical Trial Standard"), which applies to the clinical trial conducted for FSMP registration in China. This neperbedaan zinc picolinate and gluconatew regulation has been effective starting from the date of promulgation, and its previous trial version issued on October 13, 2016 has been repealed since then.